Emerald Advisers »

Intra Cellular Therapies shares owned by Emerald Advisers

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 344k 71.62
2023-09-30 $20M 382k 52.09
2023-06-30 $21M 335k 63.32